Free Trial
NASDAQ:CTSO

Cytosorbents (CTSO) Stock Price, News & Analysis

Cytosorbents logo
$1.04 +0.04 (+4.00%)
Closing price 07/3/2025 03:44 PM Eastern
Extended Trading
$1.06 +0.02 (+2.02%)
As of 07/3/2025 04:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Cytosorbents Stock (NASDAQ:CTSO)

Key Stats

Today's Range
$1.00
$1.13
50-Day Range
$0.81
$1.29
52-Week Range
$0.71
$1.61
Volume
201,856 shs
Average Volume
149,519 shs
Market Capitalization
$65.11 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.50
Consensus Rating
Buy

Company Overview

Cytosorbents Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
37th Percentile Overall Score

CTSO MarketRank™: 

Cytosorbents scored higher than 37% of companies evaluated by MarketBeat, and ranked 2119th out of 2,814 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cytosorbents has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Cytosorbents has only been the subject of 2 research reports in the past 90 days.

  • Read more about Cytosorbents' stock forecast and price target.
  • Earnings Growth

    Earnings for Cytosorbents are expected to grow in the coming year, from ($0.30) to ($0.17) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cytosorbents is -3.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cytosorbents is -3.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Cytosorbents has a P/B Ratio of 5.20. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Cytosorbents' valuation and earnings.
  • Percentage of Shares Shorted

    2.46% of the float of Cytosorbents has been sold short.
  • Short Interest Ratio / Days to Cover

    Cytosorbents has a short interest ratio ("days to cover") of 13.6, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Cytosorbents has recently decreased by 2.05%, indicating that investor sentiment is improving.
  • Dividend Yield

    Cytosorbents does not currently pay a dividend.

  • Dividend Growth

    Cytosorbents does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.46% of the float of Cytosorbents has been sold short.
  • Short Interest Ratio / Days to Cover

    Cytosorbents has a short interest ratio ("days to cover") of 13.6, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Cytosorbents has recently decreased by 2.05%, indicating that investor sentiment is improving.
  • News Sentiment

    Cytosorbents has a news sentiment score of 0.09. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.54 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 4 news articles for Cytosorbents this week, compared to 2 articles on an average week.
  • Search Interest

    Only 2 people have searched for CTSO on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cytosorbents insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 7.30% of the stock of Cytosorbents is held by insiders.

  • Percentage Held by Institutions

    Only 32.87% of the stock of Cytosorbents is held by institutions.

  • Read more about Cytosorbents' insider trading history.
Receive CTSO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cytosorbents and its competitors with MarketBeat's FREE daily newsletter.

CTSO Stock News Headlines

The $100 Trillion AI Story No One Is Telling You
Jeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.
See More Headlines

CTSO Stock Analysis - Frequently Asked Questions

Cytosorbents' stock was trading at $0.91 at the start of the year. Since then, CTSO stock has increased by 14.3% and is now trading at $1.04.

Cytosorbents Corporation (NASDAQ:CTSO) released its earnings results on Wednesday, May, 14th. The medical research company reported ($0.06) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.08) by $0.02. The medical research company had revenue of $8.73 million for the quarter, compared to the consensus estimate of $9.01 million. Cytosorbents had a negative trailing twelve-month return on equity of 105.04% and a negative net margin of 41.77%.
Read the conference call transcript
.

Shares of CTSO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cytosorbents investors own include Cuisine Solutions (CUSI), InnerScope Hearing Technologies (INND), Gilead Sciences (GILD), Johnson & Johnson (JNJ), Corning (GLW), UnitedHealth Group (UNH) and Docusign (DOCU).

Company Calendar

Last Earnings
5/14/2025
Today
7/04/2025
Next Earnings (Estimated)
8/12/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:CTSO
Employees
220
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$5.50
High Stock Price Target
$10.00
Low Stock Price Target
$1.00
Potential Upside/Downside
+428.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$20.72 million
Pretax Margin
-47.90%

Debt

Sales & Book Value

Annual Sales
$35.60 million
Price / Cash Flow
N/A
Book Value
$0.20 per share
Price / Book
5.20

Miscellaneous

Free Float
58,039,000
Market Cap
$65.11 million
Optionable
Optionable
Beta
1.19

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:CTSO) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners